NO20025720L - Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet - Google Patents
Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitetInfo
- Publication number
- NO20025720L NO20025720L NO20025720A NO20025720A NO20025720L NO 20025720 L NO20025720 L NO 20025720L NO 20025720 A NO20025720 A NO 20025720A NO 20025720 A NO20025720 A NO 20025720A NO 20025720 L NO20025720 L NO 20025720L
- Authority
- NO
- Norway
- Prior art keywords
- antifungal
- antibacterial
- antitumor activity
- new compounds
- antitumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21447800P | 2000-06-27 | 2000-06-27 | |
PCT/US2001/020334 WO2002000650A2 (en) | 2000-06-27 | 2001-06-26 | Novel compounds possessing antibacterial, antifungal or antitumor activity |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20025720D0 NO20025720D0 (no) | 2002-11-28 |
NO20025720L true NO20025720L (no) | 2003-02-26 |
Family
ID=22799223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025720A NO20025720L (no) | 2000-06-27 | 2002-11-28 | Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet |
Country Status (15)
Country | Link |
---|---|
US (2) | US6849713B2 (no) |
EP (1) | EP1294713A2 (no) |
JP (1) | JP2004501915A (no) |
KR (1) | KR20030011371A (no) |
CN (1) | CN1439006A (no) |
AU (1) | AU2001270183A1 (no) |
BR (1) | BR0112030A (no) |
CA (1) | CA2414512A1 (no) |
IL (1) | IL153119A0 (no) |
MX (1) | MXPA02012271A (no) |
NO (1) | NO20025720L (no) |
NZ (1) | NZ522839A (no) |
RU (1) | RU2003101969A (no) |
WO (1) | WO2002000650A2 (no) |
ZA (1) | ZA200209774B (no) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7122626B2 (en) | 2001-04-26 | 2006-10-17 | Genesoft Pharmceuticals, Inc. | Halogen-substitued thienyl compounds |
US20030236198A1 (en) | 2001-06-13 | 2003-12-25 | Genesoft, Inc. | Antipathogenic benzamide compounds |
CA2450628A1 (en) | 2001-06-13 | 2002-12-19 | Genesoft Pharmaceuticals, Inc. | Benzothiophene compounds having antiinfective activity |
ITTO20010633A1 (it) * | 2001-07-02 | 2003-01-02 | Univ Ferrara | Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a. |
GB0130868D0 (en) | 2001-12-24 | 2002-02-06 | Univ Strathclyde | New compounds |
US7064218B2 (en) * | 2001-12-26 | 2006-06-20 | Genelabs Technologies, Inc. | Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity |
ITMI20021455A1 (it) * | 2002-07-02 | 2004-01-02 | Ugo Raffaello Citernesi | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico |
EP1539151B1 (en) | 2002-08-02 | 2009-03-18 | Genesoft Pharmaceuticals, Inc. | Biaryl compounds having anti-infective activity |
AU2003275225A1 (en) * | 2002-09-20 | 2004-04-08 | Genelabs Technologies, Inc. | Novel aromatic compounds possessing antifungal or antibacterial activity |
JP2006505571A (ja) * | 2002-10-15 | 2006-02-16 | リゲル ファーマシューテイカルズ、インコーポレイテッド | 置換されたインドール及びhcv阻害剤としてのその使用 |
WO2004039318A2 (en) | 2002-10-25 | 2004-05-13 | Genesoft Pharmaceuticals, Inc. | Anti-infective biaryl compounds |
JP2006509027A (ja) | 2002-12-10 | 2006-03-16 | オーシェント ファーマシューティカルズ コーポレーション | (ピロールカルボキサミド)−(ベンズアミド)−(イミダゾールカルボキサミド)モチーフを有する抗菌化合物 |
EP1633349A1 (en) * | 2003-05-02 | 2006-03-15 | Elan Pharmaceuticals, Inc. | 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
WO2004099155A2 (en) * | 2003-05-02 | 2004-11-18 | Elan Pharmaceuticals, Inc. | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases |
CA2524269A1 (en) * | 2003-05-02 | 2004-11-18 | Elan Pharmaceuticals, Inc. | 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
US9512125B2 (en) * | 2004-11-19 | 2016-12-06 | The Regents Of The University Of California | Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents |
CA2647391C (en) * | 2006-04-04 | 2015-12-29 | The Regents Of The University Of California | Kinase antagonists |
KR101104666B1 (ko) * | 2006-09-06 | 2012-01-13 | 에프. 호프만-라 로슈 아게 | 단백질 키나제 억제제로서의 헤테로아릴 유도체 |
GB0619325D0 (en) | 2006-09-30 | 2006-11-08 | Univ Strathclyde | New compounds |
GB2467670B (en) * | 2007-10-04 | 2012-08-01 | Intellikine Inc | Chemical entities and therapeutic uses thereof |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
MX2010007419A (es) | 2008-01-04 | 2010-11-12 | Intellikine Inc | Ciertas entidades quimicas, composiciones y metodos. |
EP2252293B1 (en) * | 2008-03-14 | 2018-06-27 | Intellikine, LLC | Kinase inhibitors and methods of use |
US8993580B2 (en) * | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use |
WO2010006072A2 (en) | 2008-07-08 | 2010-01-14 | The Regents Of The University Of California | Mtor modulators and uses thereof |
CN102124009B (zh) * | 2008-07-08 | 2014-07-23 | 因特利凯公司 | 激酶抑制剂及其使用方法 |
US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
US8703778B2 (en) | 2008-09-26 | 2014-04-22 | Intellikine Llc | Heterocyclic kinase inhibitors |
DK2358720T3 (en) | 2008-10-16 | 2016-06-06 | Univ California | Heteroarylkinaseinhibitorer fused-ring |
US8476282B2 (en) * | 2008-11-03 | 2013-07-02 | Intellikine Llc | Benzoxazole kinase inhibitors and methods of use |
JP5789252B2 (ja) | 2009-05-07 | 2015-10-07 | インテリカイン, エルエルシー | 複素環式化合物およびその使用 |
US8980899B2 (en) | 2009-10-16 | 2015-03-17 | The Regents Of The University Of California | Methods of inhibiting Ire1 |
US8604032B2 (en) | 2010-05-21 | 2013-12-10 | Infinity Pharmaceuticals, Inc. | Chemical compounds, compositions and methods for kinase modulation |
EP2637669A4 (en) | 2010-11-10 | 2014-04-02 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and their use |
JP2014501790A (ja) | 2011-01-10 | 2014-01-23 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | イソキノリノンの調製方法及びイソキノリノンの固体形態 |
TWI592411B (zh) | 2011-02-23 | 2017-07-21 | 英特爾立秦有限責任公司 | 激酶抑制劑之組合及其用途 |
CN103930422A (zh) | 2011-07-19 | 2014-07-16 | 无限药品股份有限公司 | 杂环化合物及其用途 |
AU2012284091B2 (en) | 2011-07-19 | 2015-11-12 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
CN102952062B (zh) * | 2011-08-12 | 2016-06-08 | 中国医学科学院医药生物技术研究所 | 取代苯并杂环类化合物及其制备方法和应用 |
KR20140075693A (ko) | 2011-08-29 | 2014-06-19 | 인피니티 파마슈티칼스, 인코포레이티드 | 헤테로사이클릭 화합물 및 그의 용도 |
AU2012341028C1 (en) | 2011-09-02 | 2017-10-19 | Mount Sinai School Of Medicine | Substituted pyrazolo[3,4-D]pyrimidines and uses thereof |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US8921426B2 (en) | 2012-04-18 | 2014-12-30 | International Business Machines Corporation | Cationic bis-urea compounds as effective antimicrobial agents |
US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
EP2900673A4 (en) | 2012-09-26 | 2016-10-19 | Univ California | MODULATION OF IRE1 |
US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
DK3052485T3 (da) | 2013-10-04 | 2021-10-11 | Infinity Pharmaceuticals Inc | Heterocykliske forbindelser og anvendelser deraf |
WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
DK3119397T3 (da) | 2014-03-19 | 2022-03-28 | Infinity Pharmaceuticals Inc | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser |
US20150320755A1 (en) | 2014-04-16 | 2015-11-12 | Infinity Pharmaceuticals, Inc. | Combination therapies |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
CN104845967B (zh) | 2015-04-15 | 2020-12-11 | 苏州新海生物科技股份有限公司 | 寡聚核苷酸片段及使用其的选择性扩增目标核酸序列变异体的方法及应用 |
TWI675817B (zh) * | 2015-08-17 | 2019-11-01 | 國立臺灣大學 | 經取代的丙二醯胺化合物及其作爲抗菌藥物的用途 |
JP6980649B2 (ja) | 2015-09-14 | 2021-12-15 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | イソキノリノン誘導体の固体形態、それを製造する方法、それを含む組成物、及びそれを使用する方法 |
US10759806B2 (en) | 2016-03-17 | 2020-09-01 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
UA125216C2 (uk) | 2016-06-24 | 2022-02-02 | Інфініті Фармасьютікалз, Інк. | Комбінована терапія |
WO2018047148A1 (en) | 2016-09-12 | 2018-03-15 | Novartis Ag | Compounds for the inhibition of mirna |
CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
CA1308516C (en) * | 1987-07-06 | 1992-10-06 | J. William Lown | Oligopeptide anticancer and antiviral agents |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
EP0679088B1 (en) * | 1992-09-29 | 2002-07-10 | Inhale Therapeutic Systems | Pulmonary delivery of active fragments of parathyroid hormone |
AU7380294A (en) * | 1993-08-06 | 1995-02-28 | Synphar Laboratories, Inc. | Oligopeptide antiretroviral agents |
US5502068A (en) * | 1995-01-31 | 1996-03-26 | Synphar Laboratories, Inc. | Cyclopropylpyrroloindole-oligopeptide anticancer agents |
-
2001
- 2001-06-26 JP JP2002505774A patent/JP2004501915A/ja not_active Withdrawn
- 2001-06-26 CA CA002414512A patent/CA2414512A1/en not_active Abandoned
- 2001-06-26 EP EP01948740A patent/EP1294713A2/en not_active Withdrawn
- 2001-06-26 IL IL15311901A patent/IL153119A0/xx unknown
- 2001-06-26 WO PCT/US2001/020334 patent/WO2002000650A2/en not_active Application Discontinuation
- 2001-06-26 MX MXPA02012271A patent/MXPA02012271A/es unknown
- 2001-06-26 CN CN01811885A patent/CN1439006A/zh active Pending
- 2001-06-26 RU RU2003101969/04A patent/RU2003101969A/ru not_active Application Discontinuation
- 2001-06-26 BR BR0112030-1A patent/BR0112030A/pt not_active IP Right Cessation
- 2001-06-26 NZ NZ522839A patent/NZ522839A/en unknown
- 2001-06-26 AU AU2001270183A patent/AU2001270183A1/en not_active Abandoned
- 2001-06-26 US US09/892,327 patent/US6849713B2/en not_active Expired - Fee Related
- 2001-06-26 KR KR1020027017685A patent/KR20030011371A/ko not_active Application Discontinuation
-
2002
- 2002-10-23 US US10/277,666 patent/US6906103B2/en not_active Expired - Fee Related
- 2002-11-28 NO NO20025720A patent/NO20025720L/no not_active Application Discontinuation
- 2002-12-02 ZA ZA200209774A patent/ZA200209774B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002000650A2 (en) | 2002-01-03 |
NO20025720D0 (no) | 2002-11-28 |
BR0112030A (pt) | 2003-04-29 |
JP2004501915A (ja) | 2004-01-22 |
EP1294713A2 (en) | 2003-03-26 |
IL153119A0 (en) | 2003-06-24 |
CN1439006A (zh) | 2003-08-27 |
MXPA02012271A (es) | 2004-09-06 |
CA2414512A1 (en) | 2002-01-03 |
US6849713B2 (en) | 2005-02-01 |
US20020037856A1 (en) | 2002-03-28 |
RU2003101969A (ru) | 2004-07-10 |
US6906103B2 (en) | 2005-06-14 |
WO2002000650A3 (en) | 2002-10-24 |
AU2001270183A1 (en) | 2002-01-08 |
ZA200209774B (en) | 2004-03-02 |
KR20030011371A (ko) | 2003-02-07 |
US20030119749A1 (en) | 2003-06-26 |
NZ522839A (en) | 2004-11-26 |
WO2002000650A9 (en) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025720D0 (no) | Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet | |
NO20023516D0 (no) | Antibakterielle 3-aminokinazolinon-2,4-dioner | |
NO20033773L (no) | Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet | |
DE50014425D1 (de) | Asymmetrischer, mehrstrahliger radarsensor | |
DE60230054D1 (de) | 1h-imidazol-derivate mit cb1-agonistischer, antagonistischer oder partialer agonistischer aktivität | |
PT1140840E (pt) | Difenilureias substituidas com (.)-carboxiarilo como inibidores de raf-quinase | |
NO20010916L (no) | Nye antibakterielle isoksazolinoner | |
IS8147A (is) | Nýjar línkómýsín afleiður sem búa yfir örverueyðandi virkni | |
DE50213548D1 (de) | Substituierte 2-carba-3,5-dicyano-4-aryl-6-aminopylektive liganden | |
BR0208971B1 (pt) | produto absorvente com ajuste melhorado. | |
BR0208970B1 (pt) | produto absorvente com ajuste melhorado. | |
NO20020810D0 (no) | Nye fenylpiperaziner | |
BR0208969B1 (pt) | produto absorvente com ajuste melhorado. | |
BR0013417B1 (pt) | composiÇço aquosa. | |
NO20030100L (no) | Pleuromutilinderivater som har antibakteriell aktivitet | |
PT1389213E (pt) | Formulacoes de 3,7-diazabiciclo 3,3,1¿ como compostos antiarritmicos | |
DE60129750D1 (de) | Antiblend-, antibeschlagselement | |
PT1206476E (pt) | 9a-azalidos com actividade antibacteriana | |
DK1268475T3 (da) | Nye benzosultam-oxazolidinoner som antibakterielle midler | |
RU2003110288A (ru) | Вещество, обладающее антидепрессивной активностью | |
DE60041110D1 (de) | 6-Hydroxy-5,6-dihydrouracile als Herbizide | |
AR027978A1 (es) | 4-oxo-1,4-dihidro-3-cinolincarboxamidas como agentes antivirales | |
NO20025101D0 (no) | Nye, heterosykliske forbindelser med antiinflammatorisk aktivitet | |
DE69932256D1 (de) | Elektroluminiszierendes, organisches element | |
ITMI20001734A0 (it) | 1,3-diossolani ad attivita' antitosse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |